IN 2025, PHARMACEUTICAL SPENDING WILL REACH $1,595 BILLION, 26.1% MORE THAN IN 2020
In 2020, 48% of sales were concentrated in the US.
In 2025, the US will maintain its leadership in the pharmaceutical market with nearly 40% of global spending.
Spending on medicines increased 46% between 2010 and 2020.
SIGNIFICANT INVESTMENT DYNAMISM IN THE 2012-2026 PERIOD WITH AN INCREASE IN R&D SPENDING OF 85.4%
Between 2020 and 2026, global spending on pharmaceutical R&D will grow by 28%.
Cancer therapies lead the efforts in R&D.
R&D costs to develop a new pharmaceutical compound doubled between 2010 and 2020.
Biotechnology will account for 35% of global pharmaceutical revenues by 2026.
Pharmaceutical R&D spending in the US has increased by 7.6% annually between 2016 and 2020.
UK is the European country with the most pharmaceutical R&D companies (5% of the world total).